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Abstract 
Purpose 
In the context of adaptive radiation therapy (ART) for locally advanced cervical carcinoma (LACC), 
this study proposed an original cone-beam computed tomography (CBCT)-guided “Evolutive library” 
and evaluated it against four other known radiotherapy (RT) strategies. 
Material and methods 
For 20 patients who underwent intensity-modulated radiation therapy (IMRT) for LACC, three 
planning CTs (with empty [EB], intermediate [IB], and full [FB] bladder volumes), a CT scan at 20 
Gy and bi-weekly CBCTs for 5 weeks were performed. Five RT strategies were simulated for each 
patient: “Standard RT” was based on one IB planning CT; “internal target volume (ITV)-based RT” 
was an ITV built from the three planning CTs; “RT with one mid-treatment replanning 
(MidTtReplan)” corresponded to the standard RT with a replanning at 20 Gy; “Pretreatment library 
ART” using a planning library based on the three planning CTs; and the “Evolutive library ART”, 
which was the “Pretreatment library ART” strategy enriched by including some CBCT anatomies into 
the library when the daily clinical target volume (CTV) shape differed from the ones in the library. 
Two planning target volume (PTV) margins of 7 and 10 mm were evaluated. All the strategies were 
geometrically compared in terms of the percentage of coverage by the PTV, for the CTV and the 
organs at risk (OAR) delineated on the CBCT. Inadequate coverage of the CTV and OARs by the 
PTV was also assessed using deformable image registration. The cumulated dose distributions of each 
strategy were likewise estimated and compared for one patient. 
Results 
The “Evolutive library ART” strategy involved a number of added CBCTs: 0 for 55%; 1 for 30%; 2 
for 5%; and 3 for 10% of patients. Compared with the other four, this strategy provided the highest 
CTV geometric coverage by the PTV, with a mean (min – max) coverage of 98.5% (96.4 – 100) for 
10 mm margins and 96.2% (93.0 – 99.7) for 7 mm margins (p < 0.05). Moreover, this strategy 
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significantly decreased the geometric coverage of the bowel. CTV undercoverage by PTV occurred in 
the anterior and superior uterine regions for all strategies. The dosimetric analysis at 7 mm similarly 
demonstrated that the “Evolutive library ART” increased the V42.75Gy of the CTV by 27%, 20%, 13% 
and 28% compared with “Standard RT”, “ITV-based RT”, “MidTtReplan” and “Pretreatment library 
ART”, respectively. The dose to the bowel was also decreased by the “Evolutive library ART” 
compared with that by the other strategies. 
Conclusion 
The “Evolutive library ART” is a personalized ART strategy that comprises a pretreatment planning 
library of three CT scans, enriched for half of the patients by one to three per-treatment CBCTs. This 
original strategy increased both the CTV coverage and bowel sparing compared with all the other 
tested strategies and enables us to consider a PTV margin reduction. 
 
1. Introduction
Intensity-modulated radiation therapy (IMRT) is increasingly used as a means to reduce normal tissue 
toxicity in cervical cancer, with or without treatment intensification, such as extended-field 
radiotherapy or concomitant boost radiotherapy [1-3]. Large intrapelvic intra- and inter-fraction 
anatomic variations may impede the benefits of IMRT. When occurring in steep-dose gradients 
around tight planning target volume (PTV) margins, these variations can expose patients to both 
tumour underdosage and organs at risk (OAR) overdosage [4-6]. Inter-fraction cervical displacements 
of up to 25 mm, 36 mm, and 23 mm have been reported in the anterior-posterior (AP), superior-
inferior (SI), and left-right (LR) directions, respectively [7,8]. Moreover, uterus maximum 
displacements of 48 mm, 36 mm, and 28 mm have been reported in the AP, SI, and LR directions, 
respectively [9,10]. Uterine motion is mostly related to bladder filling, while vagina and cervix 
motion is linked to rectum filling [5,11-18]. Furthermore, large tumour regressions have been 
observed during treatment, with a mean decrease of 46% (up to 100%) of the gross cervical tumour 
volume achieved at 30 Gy [19] and 63% (up to 87%) of the cervix at the end of treatment [11,20,21]. 
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Several strategies have previously been proposed to account for these anatomic variations. Defining 
an internal target volume (ITV) is a simple solution to overcome the risk of clinical target volume 
(CTV) underdosage, yet with the drawback of increasing OAR overdosage. Replanning at mid-
treatment or following many fractions and weekly replannings have been proposed, with a deformable 
image registration (DIR)-based workflow [22-24]. Some authors have recently proposed adaptive 
radiation therapy (ART) based on a pretreatment planning library [15,25-29]. However, this approach 
may be limited in cases of cervix fixity at the planning or of per-treatment tumor shrinking. 
Nevertheless, these different strategies have not been compared in the same cohort. Moreover, no 
study has investigated the benefits of using per-treatment CTV shape variations to update a planning 
library into a tight-fitting planning library, with the aims of improving CTV coverage and OAR 
sparing [26]. 
Considering the use of ART for LACC, this work proposed an original strategy named the “cone-
beam CT (CBCT)-guided evolutive library”. This strategy takes advantage of the CBCT images 
acquired during treatment to assess patient positioning and trigger per-treatment replannings, thereby 
optimizing the treatment library by considering both tumour deformation and shrinkage. This strategy 
was simulated and compared with four others: standard planning; ITV-based planning; mid-treatment 
replanning; and a pretreatment planning library. 
 
2. Materials and methods
2.1 Patients, tumours, and treatment 
This study enrolled 20 patients with a mean age of 51 years (range, 27-68). Stage distribution, 
according to the International Federation of Gynecology and Obstetrics (FIGO) classification [30], 
was as follows: IB2, n = 7; IIA-B, n = 9; IIIA-B, n = 3; and IVA, n = 1. Histology revealed squamous 
cell carcinoma in fifteen patients and adenocarcinoma in five. All patients were treated with a 
combination of external beam radiation therapy (EBRT) and pulse-dose-rate (PDR) brachytherapy 
(BT). PDR-BT was delivered in accordance with the GEC-ESTRO recommendations [31]. EBRT 
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delivered a total dose of 45 Gy to the pelvis (supine position), at 1.8 Gy per fraction, using IMRT 
along with concomitant weekly cisplatin (40 mg/m2). All patients provided signed informed consent. 
2.2 Planning CTs and bi-weekly CBCT imaging 
Each patient underwent three planning CTs (3 mm slice thickness, Big Bore Philips) at different 
bladder volumes: empty (EB); intermediate (IB); and full (FB). One hour prior to acquiring the first 
CT (IB-CT), the patients consumed 250 mL of water. The patients then consumed an additional 500 
mL of water, and the FB CT was acquired 20 minutes later. The patients then emptied their bladders 
for the EB CT. Following the injection of intravenous contrast (IB only), CT images were obtained 
from the upper border of the L2 vertebral body to 3 cm below the ischial tuberosity. Before each 
treatment fraction, the IB procedure was reproduced. 
CBCTs (2 mm slice thickness, XVI Elekta) were acquired on days 1, 2, and 3, then bi-weekly during 
the 5 weeks of treatment, with an average of 12 (range, 9 – 17) CBCTs acquired per patient. Patients 
underwent a supplementary IB CT at mid-treatment (20 Gy), without intravenous contrast medium 
injection. All CTs, CBCTs and RT fractions were performed with the patient in a supine position with 
personalized immobilization. 
2.3 Region of interest delineation on CTs and CBCTs 
The CTV included both the primary tumour site (CTV-T) and the regional lymphatics (CTV-N). The 
CTV-T included the cervical tumour and the uterus. In the event of vaginal involvement, it also 
included 2 cm below the most caudal tumour extension in addition to the parametria. The CTV-N 
included the common, external and internal iliac vessels, along with the obturator vessels and the 
presacral lymph nodes [32]. The inguinal lymph nodes were included in cases of lower vaginal 
involvement. The delineated OARs were the rectum, bladder, and bowel; the latter included the 
sigmoid colon. The sigmoid colon was not delineated because it was not individually distinguishable 
on CBCT. 
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One experienced radiation oncologist manually delineated the CTV-T and the OAR on all CT scans 
and CBCTs. The CTV-N was only delineated on the CT scans. All delineations were validated by a 
second experienced radiation oncologist. The “CTV-T” is simplified to “CTV” in this manuscript. 
 
2.4 Definitions of RT/ART strategies and PTV margins 
Five radiotherapy (RT) strategies were geometrically simulated for each patient (Figure 1). 
(1) The standard RT was based on the planning CT with IB. 
(2) The “ITV-based RT” used an ITV created by combining the delineated CTV from the three 
planning CT scans (EB, IB, and FB), following rigid bone registration of the two CT scans (EB and 
FB) to the IB CT scan. The ITV contour was smoothed by a Gaussian filter (standard deviation, 2 
mm). 
(3) The RT strategy with one mid-treatment replanning (named “MidTtReplan”) corresponded to the 
standard RT with one additional replanning based on the CT acquired after the tumour received 20 
Gy. 
(4) The “Pretreatment library ART” was a PTV library defined from the three planning CTs. For daily 
treatment, one PTV was selected from the library. This PTV was the one that provided the maximum 
overlap (using the Sørensen-Dice similarity coefficient [DSC] [33]) between the CTV of the library 
and the daily CTV delineated in the CBCT, following rigid bone registration of the planning CT scans 
to the CBCT. 
 (5) The “Evolutive library ART” was an enriched version of this “Pretreatment library ART” and 
included new CTVs from the CBCTs in the pretreatment planning library, if the given CTV shape of 
the day differed from those in the library. Following each CBCT, if the overlap coefficients between 
the entire CTV library and the CTV of the day did not reach a defined threshold (i.e., the CTV shape 
of the day was not represented in the current library), the CBCT CTV was added to the library. Figure 
2 illustrates the evolutive library-based ART strategy. Whether each CBCT CTV was included in the 
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library depended upon the results of the similarity test. When a CBCT CTV was added to the library, 
it was considered available from the next fraction onwards. This strategy was thus off-line. All 
overlap coefficient thresholds were tested (range, 0.05-0.95). 
 
Two PTV margins were used: 10 mm, considered to be the standard margin, and 7 mm to evaluate the 
ability of a narrow PTV to cover the target during treatment. PTVs were calculated by an isotropic 
expansion of the CTVs. 
 
2.5 Morphologic analysis 
To quantify the movements represented in the pretreatment planning library, bladder volumes and 
CTV angles were measured on the planning CTs. The CTV angle was defined using three manually 
placed points at the top of the uterus, cervix, and vagina, as previously described [9,34]. Pearson’s 
coefficient (r) was calculated to assess correlations between the CTV angle and the bladder volume. 
During treatment, tumour shrinkage was quantified by calculating the volume of the CTV delineations 
on the planning CT and on the CBCTs. Vaginal displacement was also assessed by considering the 
displacement of a vaginal point defined as the centre of the inferior part (most inferior slice) of the 
CTV, after pelvic bone registration (Figure S-4b). The average of this vaginal displacement per 
patient was computed. Pearson’s coefficient was calculated to assess correlations between vaginal 
displacement and rectum coverage by the PTV. 
 
2.6 Geometric evaluation of the five strategies 
For the treatment simulations, the planning CT scans and the corresponding PTV were bone-
registered to the per-treatment imaging (CBCT and mid-treatment CT). The different strategies were 
compared using a geometric criterion. The main endpoint was the “coverage” of the volumes of 
interest (VOI) by the PTV, which required calculation of the “overlapping volume” between the PTV 
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and the VOI (CTV, bladder, rectum, or bowel). Coverage was defined as the ratio between the 
overlapping volume and the VOI volume. A total of 668 PTVs that evaluated the two margin values 
were computed (200 on the planning CTs; 468 on the per-treatment images). For each patient and 
each VOI, the mean coverage was calculated based on the patient’s CBCTs (range, 9 – 17). The mean 
coverage values that corresponded to the different strategies were compared two by two using a non-
parametric test (Wilcoxon signed-rank test). Each strategy was compared with the standard RT and 
the evolutive library strategy for each PTV margin. 
To provide a spatial analysis of the coverage of the VOIs by the PTV, a probability map was 
generated that depicted overlapping between the PTV and the volumes of interest (CTV and OAR) 
(Figure S-5). A unique template anatomy was first chosen in the cohort, corresponding to the IB CT 
scan with the median CTV volume (Stage III disease). Based on the contours of the VOIs, a rigid 
registration was first performed between the CBCTs of all the patients and the template, followed by 
deformable image registration (DIR) using the diffeomorphic Demons algorithm with a signed 
distance map [35,36]. The resulting deformation vector fields were used to propagate the overlapping 
volumes of the CBCT to the template. A map was thus generated, enabling visualization of the mean 
covered area of the CTV and the OARs for each patient. Finally, the mean of all patient maps was 
calculated for each RT strategy. DIR accuracy was estimated by calculating the Dice similarity 
coefficient (DSC). The mean (min – max) DSC values were 0.94 (0.93 – 0.95) for the CTV, 0.94 
(0.91 – 0.95) for the rectum, 0.97 (0.96 – 0.98) for the bladder, and 0.97 (0.97 – 0.98) for the bowel. 
2.7 Dosimetric evaluation of the five strategies 
To illustrate the dosimetric impact of the five strategies, each strategy was simulated for a selected 
patient, and the associated dose distributions were calculated. The patient with the lowest coverage of 
the CTV by the PTV (“standard RT” strategy) was selected. Step and shoot IMRT plans were 
generated with the Pinnacle treatment planning system (v.9.10) using 7 coplanar 6-MV photons 
beams. The dose constraints recommended by RTOG 0418 were respected. A total of eight dose plans 
were computed for each PTV margin (7 and 10 mm): on each planning CT (EB, IB, and FB); on the 
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CT at 20 Gy; on the IB planning CT with ITV; and on the per-treatment CBCTs included in the 
evolutive library (three CBCTs corresponding to the 1st, 2nd and 16th treatment fractions). The density 
overriding method was implemented to calculate the dose distribution on CT and CBCT images 
(water-air-bone: 0, -1000, 650 HU, respectively) [37]. Figure S-2 shows the dose distributions, with a 
7 mm PTV margin, of each corresponding image, along with the corresponding dose volume 
histograms (DVH). The field of view of the replanning CBCTs was extended in the cranial-caudal 
direction with the CT image that provided the most realistic body contour. 
To estimate the total received dose for each strategy, two approaches were considered. For the rectum 
and the bladder, a dose accumulation method based on deformable image registration was applied 
(with the method described in Section 2.6). The fraction doses were then warped from the CBCT to 
the planning CT using the estimated deformation vector fields [38]. The warped doses were added 
together to obtain the cumulated dose, and the DVH was calculated. The DIR method’s accuracy in 
assessing the cumulated dose, in terms of mean (min – max) DSC, was 0.93 (0.92 – 0.94) and 0.98 
(0.95 – 0.98) for the rectum and bladder. For the CTV and the bowel, due to tissue 
disappearance/appearance, DIR-based dose accumulation was not appropriate to calculate [39,40], 
and the average DVH was thus computed. The following dosimetric indices were calculated to 
compare the strategies: the CTV (in %) receiving at least 42.75 Gy (95% of the prescribed dose) 
(V42.75); V40 (in %) of the rectum and the bladder; and V35 (in cc) of the bowel. 
 
3. Results
3.1 Morphologic analysis 
The mean (min – max) CTV angles and bladder volumes were 79.7° (37.8 – 113.1°) and 50.5 cc (22.9 
– 109.9 cc) for the EB CT scans, 80° (46.9 – 113.2°) and 209.7 cc (57.9 – 713.2 cc) for IB, and 85.2°
(55.5 – 134.8°) and 282.6 cc (61.9 – 809.2 cc) for FB. The correlation between CTV angles and 
bladder volumes was low (r = 0.24; p = 0.06). 
A
cc
ep
te
d 
A
rt
ic
le
. 
The mean (min – max) of the average vagina displacement per patient were -0.5 mm (-8.6 – 5.8 mm), 
-4.4 mm (-21.4 – 6.1 mm), -5.5 mm (-18.6 – 13.3 mm) in the left-right (LR), anterior-posterior (AP) 
and superior-inferior (SI) directions, respectively. The mean (min – max) magnitude of the 
displacement was 12.3 mm (3.8 – 29.1 mm). 
Figure S-3 presents the mean PTV volume used for the strategies at planning and during the 5 weeks 
of treatment, considering each CBCT to generate a potentially new PTV. The mean weekly CTV 
decrease was 10.9 cc, resulting in mean PTV decreases of 19 cc and 23 cc for a 7 mm and 10 mm 
margin, respectively. 
3.2 Evolutive library implementation 
The right portion of Figure 3a presents the mean CTV coverage by the PTV achieved by increasing 
the DSC threshold value and, thus, the number of CBCTs added to the evolutive library (i.e., the 
number of replannings). The value of the DSC threshold, which provided a minimum mean CTV 
coverage over 95% for a 10 mm PTV margin, was 0.55. Using this threshold, the mean number of 
replannings per patient was 0.7 (range, 0 – 3). Eleven patients had no replannings; six patients had 1 
replanning, while one patient had 2 replannings, and two patients had 3 replannings. The mean time 
from the beginning of treatment to per-treatment replanning was 17 days for patients with one 
replanning, 15 and 27 days for those with two replannings, and 11, 12, and 23 days for those with 
three replannings. 
3.3 Comparison of CTV geometric coverage for all strategies 
Figure 3a and Table 1 represent the coverage of the CTV by the PTV for each strategy. Compared 
with standard RT, all strategies except the MidTtReplan significantly increased the CTV coverage. 
Compared with the evolutive library strategy, all others, except for the ITV-based RT, significantly 
decreased the CTV coverage. The mean (min – max) CTV coverage difference between the evolutive 
library and standard RT was 3.8% (0 – 26.1%). Five patients benefitted from an improved CTV 
coverage of more than 5%. Figure 4 shows that the CTV undercoverage was primarily located in the 
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anterior and superior regions of the uterus and in the posterior region of the cervix and that the 
coverage of these regions was improved by the evolutive library-based strategy. 
3.4 Comparison of OAR geometric coverage for all strategies 
Figures 3b, 3c, and 3d along with Table 1 represent the bladder, rectum, and bowel coverage by the 
PTV for each strategy, respectively. The ITV-based strategy significantly increased OAR coverage 
compared with standard RT. All except the ITV-based strategy significantly decreased the bowel 
coverage compared with the standard RT strategy. The pretreatment library-based and evolutive 
library-based strategies significantly increased the rectum coverage compared with the standard RT 
strategy. When using the evolutive library, eight patients had increased rectum coverage of more than 
5% (up to 43.3% with 10 mm PTV margin). This rectum overcoverage correlated with the anterior-
posterior (r = -0.53; p < 0.02) direction and with the magnitude of the vagina point displacement (r = 
0.76; p < 0.001). However, eight patients had decreased bowel coverage of more than 2% (up to 
6.7%). Seven patients had decreased bladder coverage of more than 5% (up to 27.5%). These OAR 
coverage differences were related to a better overlap between the CTV and the PTV, as illustrated in 
Figure S-4b. The OAR overcoverage volumes were primarily those located close to the CTV and 
occurred in the same anatomic location in all RT strategies (Figure 4). 
3.5 CTV and OAR dosimetric analysis for all strategies 
Figure 5 represents the estimated cumulated DVH of the CTV and the OARs of each strategy and the 
two PTV margins (7 and 10 mm) for one patient only. Table 2 shows the dosimetric indices of the 
CTV and OAR with respect to each strategy. For the sake of comparison, Table S-1 shows the 
corresponding geometric indices. 
The highest CTV coverage was obtained with the evolutive library strategy. However, the dosimetric 
coverage of the bladder achieved with this strategy was higher than that obtained with other strategies. 
Considering a 10 mm (respectively, 7 mm) PTV margin, the coverage of the rectum using the 
evolutive library was higher (respectively, of the same order of magnitude) than that with the other 
strategies. For the bowel, dosimetric coverage was the lowest with the evolutive library. 
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4. Discussion
Using simulations, this study sought to compare five RT strategies, including an original evolutive 
library-based ART, in the context of LACC. The evolutive library strategy consisted of using a 
pretreatment library of three planning CT scans, enriched by at least one CBCT for half of the 
selected patients. This personalized strategy automatically triggered a replanning when the CBCT 
CTV differed from the CTVs in the planning library. Compared with the four other strategies, the 
enriched “evolutive library” offers significantly better target coverage with a reduced geometric 
coverage of the bowel. Indeed, due to anatomic variations, the standard RT approach indicated a 
relative undercoverage of the CTV by the PTV, involving mainly the uterus in its anterior and 
superior part and the cervix in its posterior part to a lesser extent (Figure 4). However, the rectum and 
the bladder are at risk of being more irradiated when using the evolutive library due to the movements 
of the uterus and the vagina towards these OARs, as illustrated in Figure S-4a, b. Combining the 
evolutive library with a moderately reduced PTV margin (7 mm) compared with standard RT with a 
standard margin (10 mm) permits an increased dose of CTV and decreased dose to OARs (Table 2). 
Uterine motion has been reported to correlate with variations in bladder volume [11]. The most 
common method for defining the ITV and the pretreatment library in the literature is therefore based 
on planning CTs acquired at variable bladder volumes [11,15,26]. Our results demonstrate that the 
benefits of a bladder-based ITV and pretreatment library strategy were probably limited due to tumour 
fixation in the pelvis, as demonstrated by the absence of a correlation between the CTV angle and 
bladder volume prior to treatment. Furthermore, the pretreatment library strategy does not consider 
tumour shrinkage during the 5-week treatment (Figure S-3). Moreover, the morphologic analysis 
suggests that cervical cancer patients can be separated into four groups as follows: those whose uterus 
is mobile or not during the planning stage, and those whose uterus is mobile or not during treatment. 
For example, a pretreatment planning library handles “mover / mover” (mover at the planning and 
mover during the treatment) patients well, while the evolutive library can also adapt to the “non-
mover / mover” patients. 
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Simulations of RT strategies in cervical carcinoma patients can be achieved using geometric [27] or 
dosimetric endpoints [19,22-24,28,29]. The geometric criterion (coverage of the volumes of interest 
by the PTV) enables a large number of simulations to be performed that do not depend on a specific 
RT technique, with a drawback being a binary criterion that does not correspond with a dose gradient 
and thus, does not enable the prediction of toxicity or localized control. In our study, treatment 
strategies were compared among all patients using a geometric criterion, with dosimetric analysis 
performed for only one patient. The dosimetric evaluation produced results in accordance with the 
geometric analysis, as shown in Table S-1. 
Various ART strategies in cervical carcinoma patients have been reported in the literature, yet with 
only a limited number of patients per series (≤ 30 patients) and no clinical results. Authors have 
compared one replanning at mid-treatment to multiple replannings (up to three) triggered by dose 
accumulation using deformable image registration [22]. This dose-guided ART strategy has been 
proven to be the most effective in maintaining all patients with CTV coverage of up to 95%. Similar 
results were observed in our study when increasing the number of per-treatment replannings, from the 
mid-treatment replanning strategy to the evolutive library strategy (Table 1). This finding stresses the 
usefulness of the evolutive libraries. Both the evolutive library and mid-treatment replanning 
strategies aim to take into consideration tumour regression during treatment [19]. Moreover, a 
maximalist ART strategy with weekly replannings has also reported improved CTV coverage by 
ensuring that all patients benefit from over 95% of the prescription dose, although there were no 
overall dosimetric benefits for the OAR [23,24]. In our study, the evolutive library suggests that the 
best timing for a replanning may be in the third week after the start of treatment (11-16 fractions 
corresponding to 20-29 Gy). This finding is consistent with a study on tumour recurrence prediction 
showing that the third week of treatment (20-22 Gy) was the best timing from tissue perfusion 
analysis on MRI [41]. 
To our knowledge, our study is the first to quantify the benefits of using a planning library with 
numerous per-treatment replannings for this anatomic location. Heijkoop et al [26] described another 
original personalized strategy using a library that includes model-predicted internal target volumes 
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(sub-ITV) in a cohort of 64 patients with daily CBCTs. A similar approach has been used on a cohort 
of 16 patients [42]. In both studies, when facing logistic trouble with implementing the planning 
library (e.g., image quality, OAR filling, tumour deformations), a backup plan was used. We did not 
evaluate this approach. This strategy appears to be complementary with the proposed evaluative 
library and could potentially be combined. 
The sub-ITV library appears to also be an attractive option for avoiding the highest OAR coverage 
observed with the ITV strategy (Table 1). The use of a library based on sub-ITVs decreased the dose 
(V40 Gy) to the bladder, rectum and bowel in comparison with the ITV approach [28,42]. Recently, 
statistical shape modelling was also used to assess the dose coverage probability of 5 patients with 
weekly CTs [43]. That shape analysis appeared to be an excellent planning tool for modelling patient-
specific deformations. However, no ART strategies were simulated using this method in this study. 
The choice of PTV margin is crucial. Minimizing PTV margins permits a drastically decreased dose 
to the OARs, but risks CTV underdosing. In the literature, these margins are either isotropic, ranging 
from 3 to 15 mm [4,5,9,19,22-28,44-48], or anisotropic, ranging from 15 to 24 mm in the AP 
direction, 8 to 15 mm in the SI, and 10 to 20 mm in the LR [6,8,14,17,44,49]. Using a standard 
technique, the rational PTV margin ensuring 95% CTV coverage has been found to be 13 mm if 
isotropic and 20 mm and 10 mm in the AP and SI-LR directions, respectively, if anisotropic [50]. In 
our study, a 10 mm PTV margin was chosen as our standard because this value is widely reported in 
the literature [5,9,25,26,45,48]. A PTV margin moderately reduced to 7 mm was clearly inadequate at 
properly covering the CTV with a standard RT strategy. In this context, we found that ART permitted 
decreased PTV margins, while still maintaining satisfactory VOI coverage (Table 1; Figure 3 a, b, c, 
d). In the same perspective, a RT strategy based on two sub-ITVs with a reduced 7 mm margin 
enabled 90% of the patients to benefit from a CTV coverage higher than 95%, while this coverage 
was observed in only 64% of the patients who underwent standard RT with 16-mm margins [27]. 
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A limitation of our evolutive library is that it is an off-line approach and therefore cannot correct for 
the current fraction in the event of significant new anatomic variations, which are consequently 
considered only for the following fractions. In these cases, another option is, as mentioned previously, 
to use a 3D conformal radiation therapy back-up plan, though this option carries the risk of increasing 
the dose to the OAR [25,26]. Moreover, our strategy does not consider intra-fraction anatomic 
variations. The amplitude of intra-fraction displacement has been reported to be on average between 
0.1 and 4.2 mm for the cervix and between 1.1 and 3.1 mm for the uterus. These displacements were 
less than 5 mm in more than 97% of the cases [7,13]. Our reduced PTV margin (7 mm) therefore 
appears to include the vast majority of these intra-fraction displacements. Another limitation of our 
evolutive library strategy may be its complexity, making it difficult to implement in daily practice. 
Image processing tools must therefore be developed to guide the physician in choosing the right plan 
from the library for each day’s fraction [25], as well as in updating the library with new anatomies. 
Such an implementation could be performed either through auto-segmentation [51] or with a non-rigid 
contour propagation with model constraint [52-54]. Moreover, delineation and dose calculation for 
replanning based on the CBCT is challenging due to limitations related to Hounsfield unit 
inconsistency, low image quality, and a limited field of view. In clinical practice, replanning could 
thus be performed by acquiring a new CT scan after treatment delivery. Magnetic resonance imaging-
guided radiation therapy could also be employed instead of CBCT in the future. 
Our study has several limitations. First, the study did not evaluate the impact of intra-fraction 
variation. Second, though this geometric analysis was performed on a series of 20 patients, only one 
had a dosimetric evaluation. Furthermore, with respect to dose calculation, all CBCT image densities 
were overridden, and the field of view was extended with the CT slices. The dose accumulation in the 
rectum and bladder was also subject to uncertainties related to dose warping, even if these have 
previously been shown to be limited [38]. Moreover, bi-weekly CBCTs provided limited image 
quality for contour delineation and ART guidance. Finally, the limited number of patients did not 
permit a subgroup analysis. 
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5. Conclusion
Evolutive library ART appears to be a personalized, original ART strategy that comprises a 
pretreatment planning library combined with one to three per-treatment replannings for half of 
patients. Based on the ratio between CTV and OAR coverage, the five RT strategies tested can be 
classified in the following order of decreasing performance: evolutive library; pretreatment library; 
ITV-based strategy; mid-treatment replanning; and standard RT. The evolutive library approach thus 
appears to be particularly attractive, as it also permits PTV margins to be reduced. Clinical studies 
must now be designed and conducted to confirm the feasibility and clinical benefits of this new ART 
strategy. 
 
Figure 1: Tested RT strategies in cervical IMRT 
CBCT: cone-beam CT; RT: radiotherapy 
Each subfigure represents a simulated strategy: (1) Standard RT strategy, which uses the PTV defined 
on the intermediate bladder volume CT; (2) ITV-based RT strategy, using the PTV defined by the 
union of the three CTVs of the planning CTs with different bladder fillings (full [FB], intermediate 
[IB] and empty [EB]); (3) Standard RT strategy with an additional mid-treatment replanning at 20 
Gy; (4) the pretreatment library strategy, which uses the best PTV of the three planning CTs at each 
treatment fraction; and (5) the evolutive library strategy, which is based on the pretreatment library 
that can be enriched by including CBCT anatomies (cf. Figure 2) 
The green, red and dark blue shapes represent the FB, IB and EB CTV, respectively. The pink shape 
represents the ITV. The light blue shape represents the CTV from the CT at 20 Gy. The yellow shape 
represents the CTV (delineated on a CBCT) added into the pretreatment library.  
 
Figure 2: Schema of the evolutive library strategy (5
th
 scenario, see Figure 1). Whether a new CTV 
is included in the library depends on the result of the similarity test  
MAX_DSC: maximum Sørensen-Dice similarity coefficient; CBCT: cone-beam CT; CTV: clinical 
target volume 
The illustrated evolutive library is composed of the pretreatment library (3 CTVs) and one per-
treatment CBCT replanning that was previously added. For each CBCT of the day, the similarity test 
calculated the DSC between the daily CBCT CTV and each of the evolutive library CTVs (resulting in 
this example of four values: α, β, ɣ, and δ). The maximum DSC (MAX_DSC) enabled the identification 
of the plan of the day (1) and informed whether the CTV of the day should be added to the evolutive 
library (2). 
The red shapes represent the CTVs from the evolutive library. The green shape represents the CTV 
from the considered daily CBCT.  
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Figure 3: CTV (a), bladder (b), rectum (c) and bowel (d) coverage by the PTV provided by each 
strategy 
CTV: clinical target volume; PTV: planning target volume; MidTtReplan: mid-treatment replanning; 
ITV: internal target volume based RT; PreTt Library: pretreatment library; StandardRT: standard 
radiotherapy; CBCT: cone-beam CT 
The mean coverage of the CTV and OAR by the PTV was calculated for each patient and strategy. 
The figure presents the distribution (mean and range values) of this coverage among all patients, with 
7 mm (red) and 10 mm (blue) PTV margins. The right section represents, for the evolutive library, 
CTV and OAR coverage by the increasing the number of CBCTs that were included in the library, i.e., 
by increasing the DSC threshold. 
 
Figure 4: Template anatomy with a 10 mm PTV margin (a) and maps that represent the probability 
of an overlap between the PTV and the OAR (left side) or the CTV (right side) for each strategy (b) 
CTV: clinical target volume; PTV: planning target volume; Mid-Tt Replan: mid-treatment 
replanning; ITV-based RT: internal target volume based RT; Standard RT: standard radiotherapy 
The represented OAR are the bladder, rectum and bowel. The method used to calculate the 
overlapping probability map is described in Figure S-5.  
 
Figure 5: Estimated cumulated DVH of the CTV and the OAR of each strategy and the two PTV 
margins (7 and 10 mm) for one patient only  
StandardRT: standard radiotherapy (red); ITV-based RT: internal target volume based RT (purple); 
PreTt Library: pretreatment library (brown); MidTtReplan: mid-treatment replanning (green); 
Evolutive library (blue) 
Two approaches were considered in the estimation of the cumulated received doses: using deformable 
image registration for the rectum and the bladder and calculating the average value of the fraction 
doses for the CTV and the bowel. The selected patient was the one with the worst coverage of the CTV 
by the PTV (lowest value) with the “standard RT” strategy. 
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Table 1: CTV and OAR geometric coverage by the PTV for all strategies 
RT strategies 
PTV  
margin (mm) 
Coverage by the PTV (%) 
mean (min – max) 
CTV Bladder Rectum Bowel 
Standard RT 
7 
90.7 °° 
(63.6 – 99.9) 
20.6 
(1.9 – 46.3) 
22.4 ° 
(2.5 – 46.8) 
6.99 °° 
(0.52 – 15.0) 
10 
94.7 °° 
(70.9 – 100) 
29.7 
(6.8 – 60.5) 
34.1 ° 
(5.0 – 69.8) 
9.6 °° 
(1 – 18.9) 
ITV-based RT 
7 
95.7 * ° 
(72.8 – 100) 
30.8 ** °° 
(3.1 – 52.5) 
38.3 ** °° 
(4.5 – 76.7) 
9.9 ** °° 
(0.6 – 21.1) 
10 
97.5 * 
(78.6 – 100) 
41.1 ** °° 
(9.2 – 66.5) 
50.6 ** °° 
(10.7 – 87.8) 
12.85 ** °° 
(1.13 – 26.1) 
MidTtReplan 
7 
92 °° 
(79.5 – 98.7) 
19.7 
(4.6 – 41.1) 
22.7 
(7.1 – 47.0) 
5.56 * 
(0.77 – 13.4) 
10 
95.7 °° 
(84.7 – 99.9) 
28.9 
(10.5 – 57.4) 
37.2 
(13.2 – 72.3) 
7.9 * 
(1.3 – 17.9) 
Pretreatment library 
7 
93.8 * °° 
(64.9 – 99.7) 
19.9 
(1.7 – 41.2) 
24.6 ** 
(2.8 – 63.1) 
6 * °° 
(0.4 – 13.5) 
10 
96.6 * °° 
(72.4 – 100) 
29.5 
(6.1 – 55.7) 
37.9 ** 
(7.9 – 75.1) 
8.4 * °° 
(0.9 – 17.6) 
Evolutive library 
7 
96.2 * 
(93.0 – 99.7) 
19.3 
(8.3 – 41.2) 
26.5 ** 
(8 – 65.2) 
5.2 * 
(0.4 – 10.2) 
10 
98.5 * 
(96.4 – 100) 
29.3 
(15.4 – 55.7) 
40.6 ** 
(16.4 – 76.8) 
7.6 * 
(0.9 – 14.2) 
 
These coverage values corresponded to the percentage of the volume of interest overlap with the PTV. 
* (respectively, **) indicates that the tested strategy provided a significantly better (respectively,
worse) mean coverage across all patients compared with the standard RT strategy. 
° (respectively, °°) indicates that the tested strategy provided a significantly better (respectively, 
worse) mean coverage across all patients compared with the evolutive library strategy. 
A better strategy was defined as either increased CTV coverage or decreased OAR coverage, as 
evaluated using the signed-rank Wilcoxon test. 
PTV: planning target volume; CTV: clinical target volume; OAR: organ at risk; RT: radiotherapy; 
ITV: internal target volume 
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Table 2: Dosimetric indices of the CTV and the OAR stratified by strategy and the two PTV 
margins (7 and 10 mm) for one selected patient  
RT 
strategies 
PTV 
margin 
(mm) 
Dosimetric index of the strategy’s DVH 
mean (min – max) 
CTV 
(V42.75) (%) 
Bladder 
(V40) (%) 
Rectum 
(V40) (%) 
Bowel 
(V35) (cc) 
Standard RT 
7 
68 
(50.6 – 87.5) 
18.1 
(7.8 – 76.8) 
24.8 
(1.2 – 45.7) 
199.6 
(166.6 – 231.8) 
10 
71.2 
(54.2 – 90.1) 
23.1 
(10 – 85.7) 
39.4 
(7.6 – 59.3) 
213.1 
(177.6 – 245.4) 
ITV-based 
RT 
7 
75.4 
(62 – 89.3) 
22.1 
(8.5 - 77.9) 
34 
 (3.5 - 56.7) 
206.7 
(172.1 - 241.3) 
10 
78.6 
(64.5 – 92.7) 
28.5 
(18.7 – 87.2) 
55.4 
(16.8 – 73.6) 
233.9 
(200.5 – 271) 
MidTtReplan 
7 
82.3 
(52.8 – 99.9) 
16.9 
(3.1 - 41) 
42.9 
(14.1 – 73.5) 
171.9 
(104.4 – 219.5) 
10 
84.9 
(55.1 – 100) 
23.7 
(6.7 – 56.1) 
58.2 
(28.5 – 86.6) 
199.4 
(139.4 – 233.8) 
Pretreatment 
library 
7 
67 
(51.3 – 87.5) 
9.5 
(0 – 14.6) 
20.8 
 (3.2 – 45.7) 
205.8 
(166.6 – 236.9) 
10 
71.5 
(58.2 – 90.1) 
13 
(0.4 – 20.5) 
44.2 
(14.2 – 70.2) 
229.6 
(177.6 – 265.5) 
Evolutive 
library 
7 
94.9 
(80.3 – 99.9) 
23.2 
(4.1 – 67.1) 
33 
 (2.3 – 55.5) 
164.6 
(132.1 – 202.4) 
10 
97.2 
(83.1 – 100) 
26.6 
(2.4 – 78.8) 
65.7 
(34.4 – 87.7) 
202.4 
(177.6 – 246.7) 
The selected patient was the one with the worst coverage of the CTV by the PTV (lowest value) using 
the “standard RT” strategy. 
The mean and range values are displayed. For each volume of interest and strategy, dose indices 
were extracted from the estimated cumulated DVHs of the patient. The dosimetric objectives were ≥ 
95% for the CTV, < 40% for the bladder and rectum and < 500cc for the bowel. Two approaches 
were considered to estimate the cumulated received doses: using deformable image registration for 
the rectum and the bladder and calculating the average value of the fraction doses for the CTV and 
the bowel.  
PTV: planning target volume; DVH: dose-volume histogram; CTV: clinical target volume; RT: 
radiotherapy; ITV: internal target volume 
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